597 related articles for article (PubMed ID: 23731532)
1. Enthesitis in psoriatic arthritis.
Sakkas LI; Alexiou I; Simopoulou T; Vlychou M
Semin Arthritis Rheum; 2013 Dec; 43(3):325-34. PubMed ID: 23731532
[TBL] [Abstract][Full Text] [Related]
2. Enthesitis and Dactylitis in Psoriatic Disease: A Guide for Dermatologists.
Bagel J; Schwartzman S
Am J Clin Dermatol; 2018 Dec; 19(6):839-852. PubMed ID: 30117018
[TBL] [Abstract][Full Text] [Related]
3. Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
Lubrano E; Scarpa R
Reumatismo; 2012 Jun; 64(2):107-12. PubMed ID: 22690387
[TBL] [Abstract][Full Text] [Related]
4. Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study.
Mease PJ; Gladman DD; Deodhar A; McGonagle DG; Nash P; Boehncke WH; Gottlieb A; Xu XL; Xu S; Hsia EC; Karyekar CS; Helliwell PS
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32665433
[TBL] [Abstract][Full Text] [Related]
5. Enthesitis: A hallmark of psoriatic arthritis.
Kaeley GS; Eder L; Aydin SZ; Gutierrez M; Bakewell C
Semin Arthritis Rheum; 2018 Aug; 48(1):35-43. PubMed ID: 29429762
[TBL] [Abstract][Full Text] [Related]
6. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis.
Salvarani C; Cantini F; Olivieri I; Macchioni P; Niccoli L; Padula A; Ferri S; Portioli I
J Rheumatol; 1997 Jun; 24(6):1106-10. PubMed ID: 9195517
[TBL] [Abstract][Full Text] [Related]
7. Psoriatic arthritis.
Wollina U; Unger L; Heinig B; Kittner T
Dermatol Ther; 2010; 23(2):123-36. PubMed ID: 20415819
[TBL] [Abstract][Full Text] [Related]
8. Enthesitis in psoriatic disease.
McGonagle DG; Helliwell P; Veale D
Dermatology; 2012; 225(2):100-9. PubMed ID: 23108016
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis.
Orbai AM; Weitz J; Siegel EL; Siebert S; Savage LJ; Aydin SZ; Luime JJ; Elkayam O; Neerinckx B; Urbancek S; de Vlam K; Ritchlin CT;
J Rheumatol; 2014 Nov; 41(11):2290-4. PubMed ID: 25362713
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1692-1699. PubMed ID: 28376239
[TBL] [Abstract][Full Text] [Related]
11. Improving recognition of psoriatic arthritis.
Conaghan PG; Coates LC
Practitioner; 2009 Dec; 253(1724):15-8, 2-3. PubMed ID: 20120827
[TBL] [Abstract][Full Text] [Related]
12. An update on the diagnosis and management of psoriatic arthritis.
Weger W
G Ital Dermatol Venereol; 2011 Feb; 146(1):1-8. PubMed ID: 21317852
[TBL] [Abstract][Full Text] [Related]
13. Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis.
Siegel EL; Orbai AM; Ritchlin CT
Curr Opin Rheumatol; 2015 Mar; 27(2):111-7. PubMed ID: 25603036
[TBL] [Abstract][Full Text] [Related]
14. [Enthesitis in the context of spondyloarthritides].
Haibel H; Sieper J
Z Rheumatol; 2015 Feb; 74(1):39-48; quiz 49-50. PubMed ID: 25608675
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of psoriatic arthritis.
Balakrishnan C; Madnani N
Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S18-24. PubMed ID: 23974691
[TBL] [Abstract][Full Text] [Related]
16. Influence of Disease Manifestations on Health-related Quality of Life in Early Psoriatic Arthritis.
Wervers K; Luime JJ; Tchetverikov I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Vis M
J Rheumatol; 2018 Nov; 45(11):1526-1531. PubMed ID: 29961685
[TBL] [Abstract][Full Text] [Related]
17. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
[TBL] [Abstract][Full Text] [Related]
18. The treatment of enthesitis in psoriatic arthritis.
Kumar N; Kay LJ; Walker DJ
J Rheumatol; 2004 Nov; 31(11):2311-2; author reply 2312-3. PubMed ID: 15536671
[No Abstract] [Full Text] [Related]
19. Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity.
Tuttle KS; Vargas SO; Callahan MJ; Bae DS; Nigrovic PA
Pediatr Rheumatol Online J; 2015; 13():7. PubMed ID: 25774101
[TBL] [Abstract][Full Text] [Related]
20. MRI changes in psoriatic dactylitis--extent of pathology, relationship to tenderness and correlation with clinical indices.
Healy PJ; Groves C; Chandramohan M; Helliwell PS
Rheumatology (Oxford); 2008 Jan; 47(1):92-5. PubMed ID: 18077498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
